122 related articles for article (PubMed ID: 7168013)
21. Be Aware of the Patient With Benign Follicular Thyroid Lesion Histology and Rising Thyroglobulin Level.
Slutzky-Shraga I; Sternov Y; Robenshtock E; Tzvetov G; Benbassat C; Hirsch D
Endocr Pract; 2018 Aug; 24(8):740-745. PubMed ID: 30106632
[TBL] [Abstract][Full Text] [Related]
22. The usefulness of serum thyroglobulin in the follow-up of differentiated thyroid carcinoma in children.
Kirk JM; Mort C; Grant DB; Touzel RJ; Plowman N
Med Pediatr Oncol; 1992; 20(3):201-8. PubMed ID: 1574029
[TBL] [Abstract][Full Text] [Related]
23. Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin.
Malandrino P; Latina A; Marescalco S; Spadaro A; Regalbuto C; Fulco RA; Scollo C; Vigneri R; Pellegriti G
J Clin Endocrinol Metab; 2011 Jun; 96(6):1703-9. PubMed ID: 21450986
[TBL] [Abstract][Full Text] [Related]
24. Primary thyroid and thyroid-like follicular carcinoma of the kidney versus solitary metastatic carcinoma of the thyroid: a vexing issue.
Insabato L; Ben-Dor D; Galliani CA; Lastilla G; Bisceglia M
Virchows Arch; 2009 Jun; 454(6):717-8. PubMed ID: 19449026
[No Abstract] [Full Text] [Related]
25. [Metastasis of thyroid carcinoma. A rare case of secondary renal tumor].
Marino G; Cocimano V; Taraglio S; Testori O
Minerva Urol Nefrol; 1991; 43(2):85-8. PubMed ID: 1957235
[TBL] [Abstract][Full Text] [Related]
26. [The thyroglobulin level in blood: a reliable indicator of metastasis in the follow-up study of patients with functioning thyroid carcinoma].
Sluiter WJ; Sijperda A; Piers DA; Reitsma WD; Fleuren GJ; Oosterhuis JW; Vermey A; Doorenbos H
Ned Tijdschr Geneeskd; 1983 Jun; 127(26):1133-8. PubMed ID: 6888573
[No Abstract] [Full Text] [Related]
27. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and
Araz M; Soydal Ç; Özkan E; Akkuş P; Nak D; Küçük NÖ; Kır KM
Cancer Biother Radiopharm; 2021 Jun; 36(5):425-432. PubMed ID: 32379488
[No Abstract] [Full Text] [Related]
28. The measurement of plasma D-dimer in the follow-up after thyroidectomy for cancer: preliminary data.
Sagripanti A; Carpi A; Baicchi U
Thyroidology; 1991 Jan; 3(1):31-5. PubMed ID: 1726694
[TBL] [Abstract][Full Text] [Related]
29. Primary and secondary carcinomata with focal nodular hyperplasia in a multinodular thyroid: case report.
Kim E; Mattar AG
J Nucl Med; 1976 Nov; 17(11):983-4. PubMed ID: 978260
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of repeated recombinant human thyrotropin-stimulated thyroglobulin test in the post-surgical follow-up of very low-risk patients with differentiated thyroid carcinoma.
Cappelli C; Rotondi M; Pirola I; De Martino E; Gandossi E; Agosti B; Agabiti Rosei E; Chiovato L; Castellano M
J Endocrinol Invest; 2012 May; 35(5):459-63. PubMed ID: 22067268
[TBL] [Abstract][Full Text] [Related]
31. High serum thyroglobulin levels. Diagnostic indicators in patients with metastases from unknown primary sites.
Panza N; Lombardi G; De Rosa M; Pacilio G; Lapenta L; Salvatore M
Cancer; 1987 Nov; 60(9):2233-6. PubMed ID: 3440233
[TBL] [Abstract][Full Text] [Related]
32. Markedly elevated thyroglobulin levels in the preoperative thyroidectomy patient correlates with metastatic burden.
Oltmann SC; Leverson G; Lin SH; Schneider DF; Chen H; Sippel RS
J Surg Res; 2014 Mar; 187(1):1-5. PubMed ID: 24411304
[TBL] [Abstract][Full Text] [Related]
33. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS
J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137
[TBL] [Abstract][Full Text] [Related]
34. [The value of ultrasonographic examination in the diagnosis of recurrent kidney cancer after nephrectomy].
Kodur E
Nowotwory; 1989; 39(1):25-30. PubMed ID: 2682533
[TBL] [Abstract][Full Text] [Related]
35. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
36. [Usefulness of 99mTc-MIBI SPECT in the metastatic lesions of thyroid cancer].
Kobayashi M; Mogami T; Uchiyama M; Moriya E; Mori Y; Ohtani Y; Kawakami K; Asahara R
Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Feb; 57(3):127-32. PubMed ID: 9077095
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer.
Rubello D; Girelli ME; Casara D; Piccolo M; Perin A; Busnardo B
J Endocrinol Invest; 1990 Oct; 13(9):737-42. PubMed ID: 2292657
[TBL] [Abstract][Full Text] [Related]
38. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
39. Follow-up study of postoperative patients with thyroid cancer by thallium-201 scintigraphy and serum thyroglobulin measurement.
Iida Y; Hidaka A; Hatabu H; Kasagi K; Konishi J
J Nucl Med; 1991 Nov; 32(11):2098-100. PubMed ID: 1941144
[TBL] [Abstract][Full Text] [Related]
40. Serum thyroglobulin in the diagnosis and management of thyroid carcinoma.
Shlossberg AH; Jacobson JC; Ibbertson HK
Clin Endocrinol (Oxf); 1979 Jan; 10(1):17-27. PubMed ID: 436303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
